Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionSusquehanna International Group, Llp
Latest Disclosed Ownership40,058 shares
Latest Disclosed Value $ 1,190,123
Susquehanna International Group, Llp ownership in TVTX / Travere Therapeutics, Inc.

On May 15, 2026 - Susquehanna International Group, Llp filed a 13F-HR form disclosing ownership of 40,058 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $1,190,123 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 64,972 shares of Travere Therapeutics, Inc.. This represents a change in shares of -38.35% during the quarter. The current value of the position is $1,810,622 USD.

Susquehanna International Group, Llp has a history of taking positions in derivatives of the underlying security (TVTX) in the form of stock options. The firm currently holds call options representing 677,100 of underlying shares valued at $20,116,641 USD and put options representing 376,700 of underlying shares valued at $11,191,757 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TVTX / Travere Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 40,058 -24,914 -38.35 1,190 -52.05 0.0001
2026-02-17 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 64,972 64,972 2,483 0.0003
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 0 -109,787 -100.00 0 -100.00
2025-08-14 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 109,787 -13,473 -10.93 1,625 -26.45 0.0002
2025-05-14 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 123,260 17,215 16.23 2,209 19.55 0.0004
2025-02-14 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 106,045 67,748 176.90 1,847 245.23 0.0003
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 38,297 -66,451 -63.44 536 -37.86 0.0001
2024-08-15 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 104,748 15,682 17.61 861 25.51 0.0002
2024-05-07 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 89,066 62,215 231.70 687 184.65 0.0001
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 26,851 -37,943 -58.56 241 -58.38 0.0000
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 64,794 4,729 7.87 579 -37.20 0.0001
2023-08-11 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 60,065 -68,661 -53.34 923 -68.15 0.0002
2023-05-16 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 128,726 82,717 179.78 2,895 199.38 0.0006
2023-02-14 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 46,009 -28,665 -38.39 968 -47.45 0.0002
2022-11-14 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 74,674 58,468 360.78 1,840 368.19 0.0005
2022-08-15 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 16,206 -28,622 -63.85 393 -65.97 0.0001
2022-05-16 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 44,828 -24,548 -35.38 1,155 -46.35 0.0002
2022-04-05 2021-12-31 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 69,376 19,787 39.90 2,153 78.97 0.0003
2022-02-14 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 69,376 19,787 2,153 0.0001
2021-11-15 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 49,589 -115,985 -70.05 1,203 -50.21 0.0002
2021-08-11 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 165,574 119,176 256.86 2,416 108.46 0.0003
2021-05-17 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 46,398 27,534 145.96 1,159 125.49 0.0002
2021-03-26 2020-12-31 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 18,864 18,864 514 0.0001
2021-02-16 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 18,864 18,864 514 0.0001
2020-08-14 2020-06-30 13F RETROPHIN COM 761299106 0 -24,536 -100.00 0 -100.00
2020-05-15 2020-03-31 13F RETROPHIN COM 761299106 24,536 24,536 358 0.0001
2020-02-14 2019-12-31 13F RETROPHIN COM 761299106 0 -24,775 -100.00 0 -100.00
2019-11-14 2019-09-30 13F RETROPHIN COM 761299106 24,775 -14,199 -36.43 287 -63.35 0.0001
2019-11-14 2019-06-30 13F/A-2 RETROPHIN COM 761299106 38,974 38,974 0.00 783 0.00 0.0003
2019-08-16 2019-06-30 13F/A-1 RETROPHIN COM 761299106 38,974 0 783 0.0003
2019-08-14 2019-06-30 13F RETROPHIN COM 761299106 36,259 728
2016-02-16 2015-12-31 13F RETROPHIN COM 761299106 0 -25,062 -100.00 0 -100.00
2015-11-16 2015-09-30 13F RETROPHIN COM 761299106 25,062 14,316 133.22 508 42.70 0.0002
2015-08-14 2015-06-30 13F RETROPHIN COM 761299106 10,746 -3,224 -23.08 356 6.27 0.0002
2015-05-15 2015-03-31 13F RETROPHIN COM 761299106 13,970 -56,171 -80.08 335 -61.00 0.0002
2015-02-17 2014-12-31 13F RETROPHIN COM 761299106 70,141 70,141 859 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TRAVERE THERAPEUTICS COM Call 677,100 -5.75 20,117 -26.72 n/a n/a n/a
2026-02-17 2025-12-31 13F TRAVERE THERAPEUTICS COM Call 718,400 70.88 27,450 173.22 n/a n/a n/a
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM Call 420,400 22.00 10,048 97.00 n/a n/a n/a
2025-08-14 2025-06-30 13F TRAVERE THERAPEUTICS COM Call 344,600 266.99 5,100 203.21 n/a n/a n/a
2025-05-14 2025-03-31 13F TRAVERE THERAPEUTICS COM Call 93,900 -19.12 1,683 -16.82 n/a n/a n/a
2025-02-14 2024-12-31 13F TRAVERE THERAPEUTICS COM Call 116,100 51.17 2,022 88.27 n/a n/a n/a
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COM Call 76,800 -9.96 1,074 53.21 n/a n/a n/a
2024-08-15 2024-06-30 13F TRAVERE THERAPEUTICS COM Call 85,300 104.56 701 118.38 n/a n/a n/a
2024-05-07 2024-03-31 13F TRAVERE THERAPEUTICS COM Call 41,700 -20.11 322 -31.56 n/a n/a n/a
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM Call 52,200 -58.47 469 -58.24 n/a n/a n/a
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COM Call 125,700 113.41 1,124 24.23 n/a n/a n/a
2023-08-11 2023-06-30 13F TRAVERE THERAPEUTICS COM Call 58,900 -63.73 905 -75.25 n/a n/a n/a
2023-05-16 2023-03-31 13F TRAVERE THERAPEUTICS COM Call 162,400 327.37 3,652 357.07 n/a n/a n/a
2023-02-14 2022-12-31 13F TRAVERE THERAPEUTICS COM Call 38,000 -39.39 799 -48.28 n/a n/a n/a
2022-11-14 2022-09-30 13F TRAVERE THERAPEUTICS COM Call 62,700 10.00 1,545 11.88 n/a n/a n/a
2022-08-15 2022-06-30 13F TRAVERE THERAPEUTICS COM Call 57,000 -11.08 1,381 -16.40 n/a n/a n/a
2022-05-16 2022-03-31 13F TRAVERE THERAPEUTICS COM Call 64,100 -15.10 1,652 -29.52 n/a n/a n/a
2022-04-05 2021-12-31 13F/A TRAVERE THERAPEUTICS COM Call 75,500 11.85 2,344 43.19 n/a n/a n/a
2022-02-14 2021-12-31 13F TRAVERE THERAPEUTICS COM Call 75,500 2,344 n/a n/a n/a
2021-11-15 2021-09-30 13F TRAVERE THERAPEUTICS COM Call 67,500 1,637 n/a n/a n/a
2021-08-11 2021-06-30 13F TRAVERE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F TRAVERE THERAPEUTICS COM Call 37,800 -68.79 944 -71.40 n/a n/a n/a
2021-03-26 2020-12-31 13F/A TRAVERE THERAPEUTICS COM Call 121,100 25.49 3,301 85.35 n/a n/a n/a
2021-02-16 2020-12-31 13F TRAVERE THERAPEUTICS COM Call 121,100 3,301 n/a n/a n/a
2020-11-16 2020-09-30 13F RETROPHIN COM Call 96,500 125.47 1,781 103.78 n/a n/a n/a
2020-08-14 2020-06-30 13F RETROPHIN COM Call 42,800 -37.70 874 -12.77 n/a n/a n/a
2020-05-15 2020-03-31 13F RETROPHIN COM Call 68,700 116.72 1,002 122.67 n/a n/a n/a
2020-02-14 2019-12-31 13F RETROPHIN COM Call 31,700 -63.61 450 -55.40 n/a n/a n/a
2019-11-14 2019-09-30 13F RETROPHIN COM Call 87,100 36.52 1,009 -21.29 n/a n/a n/a
2019-08-16 2019-06-30 13F/A RETROPHIN COM Call 63,800 1,282 n/a n/a n/a
2019-11-14 2019-06-30 13F/A RETROPHIN COM Call 63,800 84.93 1,282 64.15 n/a n/a n/a
2019-08-14 2019-06-30 13F RETROPHIN COM Call 63,800 1,282 n/a n/a n/a
2019-05-15 2019-03-31 13F RETROPHIN COM Call 34,500 -90.29 781 -90.29 n/a n/a n/a
2019-02-14 2018-12-31 13F RETROPHIN COM Call 355,400 -2.04 8,043 -22.83 n/a n/a n/a
2018-11-14 2018-09-30 13F RETROPHIN COM Call 362,800 2,021.64 10,423 2,136.70 n/a n/a n/a
2018-08-14 2018-06-30 13F RETROPHIN COM Call 17,100 -63.30 466 -55.28 n/a n/a n/a
2018-05-15 2018-03-31 13F RETROPHIN COM Call 46,600 -32.27 1,042 -28.14 n/a n/a n/a
2018-02-14 2017-12-31 13F RETROPHIN COM Call 68,800 -19.34 1,450 -31.70 n/a n/a n/a
2017-11-14 2017-09-30 13F RETROPHIN COM Call 85,300 -10.30 2,123 15.13 n/a n/a n/a
2017-08-15 2017-06-30 13F RETROPHIN COM Call 95,100 14.03 1,844 19.74 n/a n/a n/a
2017-05-15 2017-03-31 13F RETROPHIN COM Call 83,400 -61.37 1,540 -62.32 n/a n/a n/a
2017-02-14 2016-12-31 13F RETROPHIN COM Call 215,900 -11.99 4,087 -25.56 n/a n/a n/a
2016-11-14 2016-09-30 13F RETROPHIN COM Call 245,300 -10.51 5,490 12.45 n/a n/a n/a
2016-08-15 2016-06-30 13F RETROPHIN COM Call 274,100 40.85 4,882 83.67 n/a n/a n/a
2016-05-13 2016-03-31 13F RETROPHIN COM Call 194,600 3.90 2,658 -26.43 n/a n/a n/a
2016-02-26 2015-12-31 13F/A RETROPHIN COM Call 187,300 82.38 3,613 73.62 n/a n/a n/a
2016-02-16 2015-12-31 13F RETROPHIN COM Call 77,000 1,485 n/a n/a n/a
2015-11-16 2015-09-30 13F RETROPHIN COM Call 102,700 -55.19 2,081 -72.61 n/a n/a n/a
2015-08-14 2015-06-30 13F RETROPHIN COM Call 229,200 -61.58 7,598 -46.85 n/a n/a n/a
2015-05-15 2015-03-31 13F RETROPHIN COM Call 596,600 510.02 14,295 1,094.24 n/a n/a n/a
2015-02-17 2014-12-31 13F RETROPHIN COM Call 97,800 214.47 1,197 325.98 n/a n/a n/a
2014-11-17 2014-09-30 13F RETROPHIN COM Call 31,100 281 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TRAVERE THERAPEUTICS COM Put 376,700 234.84 11,192 160.38 n/a n/a n/a
2026-02-17 2025-12-31 13F TRAVERE THERAPEUTICS COM Put 112,500 24.31 4,299 98.80 n/a n/a n/a
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM Put 90,500 -62.49 2,163 -39.46 n/a n/a n/a
2025-08-14 2025-06-30 13F TRAVERE THERAPEUTICS COM Put 241,300 699.01 3,571 560.07 n/a n/a n/a
2025-05-14 2025-03-31 13F TRAVERE THERAPEUTICS COM Put 30,200 -57.88 541 -56.69 n/a n/a n/a
2025-02-14 2024-12-31 13F TRAVERE THERAPEUTICS COM Put 71,700 -49.26 1,249 -36.79 n/a n/a n/a
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COM Put 141,300 82.79 1,977 211.18 n/a n/a n/a
2024-08-15 2024-06-30 13F TRAVERE THERAPEUTICS COM Put 77,300 58.73 635 69.33 n/a n/a n/a
2024-05-07 2024-03-31 13F TRAVERE THERAPEUTICS COM Put 48,700 35.65 375 16.46 n/a n/a n/a
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM Put 35,900 -36.23 323 -35.98 n/a n/a n/a
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COM Put 56,300 -62.24 503 -78.03 n/a n/a n/a
2023-08-11 2023-06-30 13F TRAVERE THERAPEUTICS COM Put 149,100 -27.62 2,290 -50.56 n/a n/a n/a
2023-05-16 2023-03-31 13F TRAVERE THERAPEUTICS COM Put 206,000 698.45 4,633 754.61 n/a n/a n/a
2023-02-14 2022-12-31 13F TRAVERE THERAPEUTICS COM Put 25,800 15.18 543 -1.81 n/a n/a n/a
2022-11-14 2022-09-30 13F TRAVERE THERAPEUTICS COM Put 22,400 93.10 552 96.44 n/a n/a n/a
2022-08-15 2022-06-30 13F TRAVERE THERAPEUTICS COM Put 11,600 -61.07 281 -63.41 n/a n/a n/a
2022-05-16 2022-03-31 13F TRAVERE THERAPEUTICS COM Put 29,800 -41.68 768 -51.58 n/a n/a n/a
2022-04-05 2021-12-31 13F/A TRAVERE THERAPEUTICS COM Put 51,100 -52.77 1,586 -39.56 n/a n/a n/a
2022-02-14 2021-12-31 13F TRAVERE THERAPEUTICS COM Put 51,100 1,586 n/a n/a n/a
2021-11-15 2021-09-30 13F TRAVERE THERAPEUTICS COM Put 108,200 641.10 2,624 1,131.92 n/a n/a n/a
2021-08-11 2021-06-30 13F TRAVERE THERAPEUTICS COM Put 14,600 -29.81 213 -58.96 n/a n/a n/a
2021-05-17 2021-03-31 13F TRAVERE THERAPEUTICS COM Put 20,800 -61.34 519 -64.60 n/a n/a n/a
2021-03-26 2020-12-31 13F/A TRAVERE THERAPEUTICS COM Put 53,800 -19.94 1,466 18.13 n/a n/a n/a
2021-02-16 2020-12-31 13F TRAVERE THERAPEUTICS COM Put 53,800 1,466 n/a n/a n/a
2020-11-16 2020-09-30 13F RETROPHIN COM Put 67,200 2.28 1,241 -7.46 n/a n/a n/a
2020-08-14 2020-06-30 13F RETROPHIN COM Put 65,700 16.28 1,341 62.74 n/a n/a n/a
2020-05-15 2020-03-31 13F RETROPHIN COM Put 56,500 79.94 824 84.75 n/a n/a n/a
2020-02-14 2019-12-31 13F RETROPHIN COM Put 31,400 -50.47 446 -39.32 n/a n/a n/a
2019-11-14 2019-09-30 13F RETROPHIN COM Put 63,400 -77.76 735 -87.17 n/a n/a n/a
2019-08-16 2019-06-30 13F/A RETROPHIN COM Put 285,100 5,728 n/a n/a n/a
2019-11-14 2019-06-30 13F/A RETROPHIN COM Put 285,100 136.01 5,728 109.51 n/a n/a n/a
2019-08-14 2019-06-30 13F RETROPHIN COM Put 285,100 5,728 n/a n/a n/a
2019-05-15 2019-03-31 13F RETROPHIN COM Put 120,800 -7.43 2,734 -7.42 n/a n/a n/a
2019-02-14 2018-12-31 13F RETROPHIN COM Put 130,500 21.06 2,953 -4.65 n/a n/a n/a
2018-11-14 2018-09-30 13F RETROPHIN COM Put 107,800 3,097 n/a n/a n/a
2018-08-14 2018-06-30 13F RETROPHIN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F RETROPHIN COM Put 14,800 12.98 331 19.93 n/a n/a n/a
2018-02-14 2017-12-31 13F RETROPHIN COM Put 13,100 -12.67 276 -26.01 n/a n/a n/a
2017-11-14 2017-09-30 13F RETROPHIN COM Put 15,000 38.89 373 78.47 n/a n/a n/a
2017-08-15 2017-06-30 13F RETROPHIN COM Put 10,800 209 n/a n/a n/a
2017-05-15 2017-03-31 13F RETROPHIN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F RETROPHIN COM Put 80,100 4.57 1,516 -11.55 n/a n/a n/a
2016-11-14 2016-09-30 13F RETROPHIN COM Put 76,600 -54.10 1,714 -42.33 n/a n/a n/a
2016-08-15 2016-06-30 13F RETROPHIN COM Put 166,900 26.15 2,972 64.47 n/a n/a n/a
2016-05-13 2016-03-31 13F RETROPHIN COM Put 132,300 53.84 1,807 8.92 n/a n/a n/a
2016-02-26 2015-12-31 13F/A RETROPHIN COM Put 86,000 44.30 1,659 37.45 n/a n/a n/a
2016-02-16 2015-12-31 13F RETROPHIN COM Put 31,000 598 n/a n/a n/a
2015-11-16 2015-09-30 13F RETROPHIN COM Put 59,600 207.22 1,207 87.71 n/a n/a n/a
2015-08-14 2015-06-30 13F RETROPHIN COM Put 19,400 -95.60 643 -93.91 n/a n/a n/a
2015-05-15 2015-03-31 13F RETROPHIN COM Put 440,700 10,559 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.